The FTC filed a lawsuit against telehealth company Hims & Hers on Wednesday alleging it disclosed sensitive health information with third parties, including Meta, the parent company of Instagram and Facebook, as well as Snap. The suit also alleges that Hims & Hers deceived consumers with billing and subscription practices that charged people before they received services and made it difficult to cancel. Hims & Hers provides telehealth services connecting potential patients with a health professional for both prescription and over-the-counter medications to treat conditions like hair loss, obesity, erectile dysfunction, premature ejaculation, and mental health issues. The complaint specifically mentions premature ejaculation and erectile dysfunction as reasons why consumers might want to keep their health data private from advertisers. The FTC has been conducting an investigation into Hims & Hers since 2023 and accused the San Francisco-based company of charging consumers immediately after they submit an intake form, rather than after a consultation with a medical professional as advertised. The consumers are often signed up for subscriptions before having a chance to properly review or approve it, according to the FTC.